Mitsui Chemicals, Inc. (TYO:4183)
3,126.00
-150.00 (-4.58%)
May 14, 2025, 3:30 PM JST
Mitsui Chemicals Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Revenue | 1,809,164 | 1,749,743 | 1,879,547 | 1,612,688 | 1,211,725 | Upgrade
|
Revenue Growth (YoY) | 3.40% | -6.91% | 16.55% | 33.09% | -9.50% | Upgrade
|
Cost of Revenue | 1,420,872 | 1,378,946 | 1,498,054 | 1,233,948 | 917,883 | Upgrade
|
Gross Profit | 388,292 | 370,797 | 381,493 | 378,740 | 293,842 | Upgrade
|
Selling, General & Admin | 295,352 | 220,769 | 225,718 | 188,282 | 165,680 | Upgrade
|
Research & Development | - | 44,695 | 42,954 | 38,124 | 33,802 | Upgrade
|
Other Operating Expenses | 27,033 | -525 | -1,614 | -690 | -1,830 | Upgrade
|
Operating Expenses | 322,385 | 284,901 | 290,765 | 245,977 | 212,715 | Upgrade
|
Operating Income | 65,907 | 85,896 | 90,728 | 132,763 | 81,127 | Upgrade
|
Interest Expense | -14,702 | -7,866 | -6,078 | -4,083 | -4,811 | Upgrade
|
Interest & Investment Income | 8,013 | 6,312 | 5,010 | 2,457 | 2,152 | Upgrade
|
Earnings From Equity Investments | 12,429 | 12,302 | 21,693 | 25,819 | 5,989 | Upgrade
|
Currency Exchange Gain (Loss) | - | 6,922 | - | - | - | Upgrade
|
Other Non Operating Income (Expenses) | - | -3,081 | -2,594 | 3,284 | 1,746 | Upgrade
|
EBT Excluding Unusual Items | 71,647 | 100,485 | 108,759 | 160,240 | 86,203 | Upgrade
|
Impairment of Goodwill | - | 939 | - | 7,246 | - | Upgrade
|
Gain (Loss) on Sale of Investments | - | 2,230 | 23,124 | -4,978 | -3 | Upgrade
|
Gain (Loss) on Sale of Assets | - | -6,167 | -7,136 | -5,050 | -3,392 | Upgrade
|
Asset Writedown | - | -24,156 | -7,455 | -16,183 | -8,050 | Upgrade
|
Other Unusual Items | - | - | -14 | -1 | -515 | Upgrade
|
Pretax Income | 71,647 | 73,331 | 117,278 | 141,274 | 74,243 | Upgrade
|
Income Tax Expense | 29,018 | 19,556 | 27,140 | 22,723 | 10,024 | Upgrade
|
Earnings From Continuing Operations | 42,629 | 53,775 | 90,138 | 118,551 | 64,219 | Upgrade
|
Minority Interest in Earnings | -10,387 | -3,776 | -7,202 | -8,561 | -6,346 | Upgrade
|
Net Income | 32,242 | 49,999 | 82,936 | 109,990 | 57,873 | Upgrade
|
Net Income to Common | 32,242 | 49,999 | 82,936 | 109,990 | 57,873 | Upgrade
|
Net Income Growth | -35.52% | -39.71% | -24.60% | 90.05% | 52.52% | Upgrade
|
Shares Outstanding (Basic) | 189 | 190 | 192 | 195 | 194 | Upgrade
|
Shares Outstanding (Diluted) | 189 | 190 | 192 | 195 | 194 | Upgrade
|
Shares Change (YoY) | -0.57% | -1.16% | -1.11% | 0.16% | -0.23% | Upgrade
|
EPS (Basic) | 170.56 | 262.99 | 431.17 | 565.45 | 298.00 | Upgrade
|
EPS (Diluted) | 170.56 | 262.99 | 431.17 | 565.45 | 298.00 | Upgrade
|
EPS Growth | -35.14% | -39.01% | -23.75% | 89.75% | 52.87% | Upgrade
|
Free Cash Flow | 79,288 | 17,271 | -31,106 | -14,483 | 99,419 | Upgrade
|
Free Cash Flow Per Share | 419.43 | 90.84 | -161.72 | -74.46 | 511.94 | Upgrade
|
Dividend Per Share | - | 140.000 | 120.000 | 115.000 | 100.000 | Upgrade
|
Dividend Growth | - | 16.67% | 4.35% | 15.00% | - | Upgrade
|
Gross Margin | 21.46% | 21.19% | 20.30% | 23.48% | 24.25% | Upgrade
|
Operating Margin | 3.64% | 4.91% | 4.83% | 8.23% | 6.69% | Upgrade
|
Profit Margin | 1.78% | 2.86% | 4.41% | 6.82% | 4.78% | Upgrade
|
Free Cash Flow Margin | 4.38% | 0.99% | -1.65% | -0.90% | 8.21% | Upgrade
|
EBITDA | 165,675 | 181,145 | 182,808 | 216,985 | 157,748 | Upgrade
|
EBITDA Margin | 9.16% | 10.35% | 9.73% | 13.46% | 13.02% | Upgrade
|
D&A For EBITDA | 99,768 | 95,249 | 92,080 | 84,222 | 76,621 | Upgrade
|
EBIT | 65,907 | 85,896 | 90,728 | 132,763 | 81,127 | Upgrade
|
EBIT Margin | 3.64% | 4.91% | 4.83% | 8.23% | 6.69% | Upgrade
|
Effective Tax Rate | 40.50% | 26.67% | 23.14% | 16.08% | 13.50% | Upgrade
|
Updated Feb 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.